EP1280795B1 — N-substituted carbamoyloxyalkyl-azolium derivatives
Assigned to Basilea Pharmaceutica AG · Expires 2005-03-23 · 21y expired
What this patent protects
N-substituted carbamoyloxyalkyl-azolium derivatives of general formula (I), wherein Q, Y, R?1, R2, R3¿, Y and X- are as defined in the claims and the description as well as salts, hydrates or solvates thereof. The compounds of the present invention have antifungal activity and ar…
USPTO Abstract
N-substituted carbamoyloxyalkyl-azolium derivatives of general formula (I), wherein Q, Y, R?1, R2, R3¿, Y and X- are as defined in the claims and the description as well as salts, hydrates or solvates thereof. The compounds of the present invention have antifungal activity and are useful for the treatment of fungal diseases.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.